Exenatide Twice Daily Versus Glimepiride for Prevention of Glycemic Deterioration in Patients With Type 2 Diabetes With Metformin Failure (EUREXA): An Open-Label, Randomized Controlled Trial

Study Questions:

What is the comparative efficacy of exenatide versus glimepiride for durability of glycemic control in patients with type 2 diabetes inadequately controlled by metformin alone?